Biomaxima
Research Biomaxima (BMX) on Bullrun: market cap PLN 42.60M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBMX
- ExchangeWAR
- CountryPoland
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyPLN
- Market capPLN 42.60M
- Financial periodQ1 2026
- RevenuePLN 14.12M
- Net incomePLN 328.00K
- Free cash flow-PLN 2.62M
- Gross margin55.9%
Valuation Snapshot
latest market cap is PLN 42.60M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2023 | PLN 46.79M | PLN 586.00K | n/a | 77.7% | 0.14 | PLN 1.50M | n/a | PLN 46.97M |
| FY2022 | PLN 143.87M | PLN 28.89M | n/a | 92.0% | 6.48 | PLN 12.91M | n/a | PLN 52.46M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | PLN 42.60M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 PLN.
| Year | Dividends/share |
|---|---|
| FY2023 | 0.5 PLN |
| FY2022 | 0.45 PLN |
About Biomaxima
BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biomaxima's market cap?
Biomaxima's market capitalization is PLN 42.60M.
What does Biomaxima do?
BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements.